Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,589 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of chiglitazar, a novel peroxisome proliferator-activated receptor pan-agonist, in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial (CMAP).
Ji L, Song W, Fang H, Li W, Geng J, Wang Y, Guo L, Cai H, Yang T, Li H, Yang G, Li Q, Liu K, Li S, Liu Y, Shi F, Li X, Gao X, Tian H, Ji Q, Su Q, Zhou Z, Wang W, Zhou Z, Li X, Xu Y, Ning Z, Cao H, Pan D, Yao H, Lu X, Jia W. Ji L, et al. Among authors: geng j. Sci Bull (Beijing). 2021 Aug 15;66(15):1571-1580. doi: 10.1016/j.scib.2021.03.019. Epub 2021 Mar 23. Sci Bull (Beijing). 2021. PMID: 36654286 Free article. Clinical Trial.
Henagliflozin monotherapy in patients with type 2 diabetes inadequately controlled on diet and exercise: A randomized, double-blind, placebo-controlled, phase 3 trial.
Lu J, Fu L, Li Y, Geng J, Qin L, Li P, Zheng H, Sun Z, Li Y, Zhang L, Sun Y, Chen D, Qin G, Lu W, Guo Y, Zhang Y, Liu H, Zhang T, Zou J. Lu J, et al. Among authors: geng j. Diabetes Obes Metab. 2021 May;23(5):1111-1120. doi: 10.1111/dom.14314. Epub 2021 Jan 31. Diabetes Obes Metab. 2021. PMID: 33417292 Clinical Trial.
Efficacy and safety of DBPR108 (prusogliptin) as an add-on to metformin therapy in patients with type 2 diabetes: A 24-week, multi-centre, randomized, double-blind, placebo-controlled, superiority, phase III clinical trial.
Xu J, Ling H, Geng J; Investigators; Huang Y, Xie Y, Zheng H, Niu H, Zhang T, Yuan J, Xiao X. Xu J, et al. Among authors: geng j. Diabetes Obes Metab. 2022 Nov;24(11):2232-2240. doi: 10.1111/dom.14810. Epub 2022 Jul 22. Diabetes Obes Metab. 2022. PMID: 35791646 Free PMC article. Clinical Trial.
Analysis of the Application Value of Ultrasound Three-Dimensional Speckle Tracking Technology Combined with Thyroid Autoantibodies and Hormones in the Diagnosis and Treatment of Graves' Disease.
Xu Y, Peng S, Qin L, Sun D, Geng J, Liu Q. Xu Y, et al. Among authors: geng j. Evid Based Complement Alternat Med. 2022 Jul 6;2022:7774283. doi: 10.1155/2022/7774283. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35845595 Free PMC article. Retracted.
2,589 results